
GLP-1 drugs linked to lower risk of knee replacement in knee osteoarthritis
A shared Discover Magazine report says a records-based study found people with knee osteoarthritis taking GLP-1 receptor agonists had a significantly lower long-term risk of knee replacement, strongest with semaglutide and tirzepatide and with longer treatment. Louis added only hashtags; this is observational data.
